Get the Stockscreener App
16.23
1.46%
-0.22
Delcath Systems Inc stock is traded at $16.23, with a volume of 235.91K.
It is down -1.46% in the last 24 hours and up +31.79% over the past month.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
See More
Previous Close:
$16.45
Open:
$16.65
24h Volume:
235.91K
Relative Volume:
0.55
Market Cap:
$595.49M
Revenue:
$2.07M
Net Income/Loss:
$-47.68M
P/E Ratio:
-5.7553
EPS:
-2.82
Net Cash Flow:
$-31.31M
1W Performance:
+3.91%
1M Performance:
+31.79%
6M Performance:
+108.09%
1Y Performance:
+248.60%
1-Day Range:
$16.00
$16.97
1-Week Range:
$15.06
$16.97
52-Week Range:
$3.70
$16.97
Delcath Systems Inc Stock (DCTH) Company Profile
Name
Delcath Systems Inc
Sector
Industry
Phone
(518) 743-8892
Address
566 QUEENSBURY AVENUE, QUEENSBURY, NY
Compare DCTH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DCTH
Delcath Systems Inc
|
16.20 | 595.49M | 2.07M | -47.68M | -31.31M | -2.82 |
|
ABT
Abbott Laboratories
|
128.84 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.35 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.79 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
89.81 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.03 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Delcath Systems Inc Stock (DCTH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-28-24 | Initiated | Craig Hallum | Buy |
| May-14-24 | Initiated | Stephens | Overweight |
| Jul-26-22 | Resumed | Canaccord Genuity | Buy |
| Dec-10-21 | Initiated | H.C. Wainwright | Buy |
| Mar-09-21 | Initiated | Canaccord Genuity | Buy |
| Jan-05-21 | Initiated | BTIG Research | Buy |
| Jun-01-20 | Initiated | Laidlaw | Buy |
View All
Delcath Systems Inc Stock (DCTH) Latest News
Delcath Systems: Strong Position In Metastatic Uveal Melanoma, But Broader Growth Challenges Ahead - Seeking Alpha
How should investors view Delcath Systems Inc (DCTH)? - US Post News
Law Offices of Todd M. Garber Announces Class Action Lawsuit Against Delcath Systems, Inc. - AOL
16,978 Shares in Delcath Systems, Inc. (NASDAQ:DCTH) Acquired by Baader Bank Aktiengesellschaft - MarketBeat
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Update - MarketBeat
Why You Should Keep An Eye On Delcath Systems - RTTNews
Where are the Opportunities in (DCTH) - Stock Traders Daily
Delcath Systems (DCTH) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance
Biliary Tract Cancer Market Poised for Significant Growth from - openPR
Liver Cancer Treatment Pioneer Delcath Takes Center Stage at Elite Healthcare Summit - StockTitan
Rosalind Advisors, Inc. Expands Stake in Delcath Systems Inc. - GuruFocus.com
retail investors who own 58% along with institutions invested in Delcath Systems, Inc. (NASDAQ:DCTH) saw increase in their holdings value last week - Yahoo Finance
Delcath Systems, Inc. to Host Earnings Call - ACCESS Newswire
Delcath SystemsSuper Growth Projections - MSN
Delcath Systems (NASDAQ:DCTH) Hits New 1-Year HighTime to Buy? - MarketBeat
Barclays PLC Invests $104,000 in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems Stock Soars to 52-Week High of $15.7 Amidst Surge - Investing.com India
Sensus leads med-tech stock rebound in 2024, year closes with modest sector gain - BioWorld Online
When (DCTH) Moves Investors should Listen - Stock Traders Daily
Delcath Systems stock soars to 52-week high of $13.34 - MSN
Craig Hallum Raises Delcath Systems (NASDAQ:DCTH) Price Target to $21.00 - Defense World
Delcath Systems (NASDAQ:DCTH) Price Target Raised to $21.00 - MarketBeat
Delcath Systems, Inc.'s (NASDAQ:DCTH) P/S Is Still On The Mark Following 31% Share Price Bounce - Simply Wall St
Delcath Systems, Inc. (NASDAQ:DCTH) Short Interest Down 23.0% in December - Defense World
Delcath Systems stock retains Buy rating as Craig-Hallum raises price target by 17% - MSN
Delcath Systems stock soars to 52-week high of $13.34 By Investing.com - Investing.com Canada
Delcath Systems, Inc. (NASDAQ:DCTH) Sees Large Decrease in Short Interest - MarketBeat
14 Best 52-Week High Stocks To Buy According to Analysts - Insider Monkey
Top 5 Small-cap Medical Device Stocks (Updated January 2025) - Investing News Network
Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now - Insider Monkey
Jane Street Group LLC Makes New Investment in Delcath Systems, Inc. (NASDAQ:DCTH) - Defense World
Delcath Systems, Inc. Releases Preliminary Financial Results and Updates Corporate Presentation - Defense World
Recent Price Trend in Delcath Systems (DCTH) is Your Friend, Here's Why - Yahoo Finance
Delcath Systems (NASDAQ:DCTH) Earns Buy Rating from HC Wainwright - MarketBeat
Analyst Expectations For Delcath Systems's Future - Benzinga
Delcath Systems sees Q4 revenue $15.1M, consensus $12.42M - MSN
Biliary Tract Cancer Market Expected to Experience Major Growth - openPR
Delcath Systems Reports Strong 2024 Financial Performance - TipRanks
Delcath stock soars on Q4 and 2024 revenue beat By Investing.com - Investing.com Canada
Delcath stock soars on Q4 and 2024 revenue beat - Investing.com
Delcath reports preliminary Q4 and 2024 financials - Investing.com India
Delcath Systems Reports Strong Q4: $15.1M Revenue, HEPZATO Sales Drive 80%+ Margins - StockTitan
Delcath Systems Inc Stock (DCTH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Delcath Systems Inc Stock (DCTH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aharon Gil | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,069,710 |
| SALAMON STEVEN A J | Director |
Mar 19 '24 |
Buy |
3.72 |
26,882 |
100,001 |
1,121,025 |
1.81%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):